Tabula Rasa HealthCare (TRHC) Tops Q4 EPS by 9c, Revenues Beat; Offers Q1 & FY20 Revenue Guidance Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Tabula Rasa HealthCare Announces Fourth Quarter and Full Year 2019 Results
February 27, 2020 4:06 PM ESTMOORESTOWN, N.J., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced its financial results for the fourth quarter and full year ended December 31, 2019.
Full Year 2019 Highlights
Total revenue increased 39% to $284.7 million;Non-GAAP Adjusted EBITDA increased 29% to $37.9 million;Non-GAAP Adjusted diluted EPS increased to $0.79 from $0.77;Product revenue increased 22% to $137.1 million, driven by growth in the number of participants enrolled in PACE organizations of 14% and an incremental $9.8 million of cross-sell revenue recognized during 2019;... More